Image Source: Unsplash

Marijuana stocks got a boost this week (+5.7%) following the reintroduction of a long-awaited bipartisan banking bill - the Secure and Fair Enforcement (SAFE) Banking Act - with the goal of offering crucial banking and financial services to legitimate marijuana businesses while also protecting banks that collaborate with them from federal backlash. With the bill’s reintroduction, there’s now a clear route for the SAFE Banking Act to make its way through the Senate Banking Committee and ultimately be voted on in the Senate.

The 7 constituents in the munKNEE American Cannabis MSOs Index are ranked below, in descending order, as to their stock performances for the month of April and YTD with:

• their likelihood of Financial Distress within the next 2 years (Source:macroaxis.com),
• their average Wall Street Analyst 12-month Price Target,
• their degree of Short Interest (the number of shorted shares divided by the number of shares outstanding),
• their percentage of Insider Ownership (directors and senior officers or other beneficial holders with 10% or more of the common shares) as sourced from seekingalpha.com and
• their current market capitalizations.

1. TerrAscend (TRSSF): UP 10.5% in April; UP 52.7% YTD  
   • 11 analysts:
   • have an average 12-month price target representing a 42.9% increase from its current price and
   • have a consensus BUY rating.
   • In addition, TRSSF has:
     • a 64% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • only a 6.6% Insider Ownership and
     • a Market Cap of $536M.
2. Verano (VRNOF): UP 2.1% in April; DOWN 3.0% YTD 
   • 13 analysts:
   • have an average 12-month price target representing a 235.6% increase from its current price and
   • have a consensus STRONG BUY rating.
   • In addition, VRNOF has:
     • a 64% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • only a 2.1% Insider Ownership and
     • a Market Cap of $1.01B.
3. Cresco Labs (CRLBF): UP 0.6% in April; DOWN 10.9% YTD  
   • 12 analysts:
   • have an average 12-month price target representing a 252.6% increase from its current price and
   • have a consensus BUY rating.
   • In addition, CRLBF has:
     • a 76% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • a 22.1% Insider Ownership and
     • a Market Cap of $637M.
4. Trulieve (TCNNF): DOWN 3.8% in April; DOWN 28.8% YTD
   • 19 analysts:
   • have an average 12-month price target representing a 240.7% increase from its current price and
   • have a consensus STRONG BUY rating.
   • In addition, TCNNF has:
     • a 69% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • a 18.7% Insider Ownership and
     • a Market Cap of $978M.
5. Columbia Care (CCHWF): DOWN 5.8% in April; DOWN 34.7% YTD  
   • 2 analysts:
   • have an average 12-month price target representing a 708.2% increase from its current price and
   • have a consensus STRONG BUY rating.
   • In addition, CCHWF has:
     • a 72% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • a 17.9% Insider Ownership and
     • a Market Cap of $196M.
6. Green Thumb (GTBIF): DOWN 7.8% in April; DOWN 15.8% YTD  
   • 21 analysts:
   • have an average 12-month price target representing a 170.3% increase from its current price and
   • have a consensus STRONG BUY rating.
   • In addition, GTBIF has:
     • a 10% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • a 14.3% Insider Ownership and
     • a Market Cap of $1.73B.
7. Curaleaf (CURLF): DOWN 9.2% in April; DOWN 34.5% YTD  
   • 20 analysts:
   • have an average 12-month price target representing a 323.0% increase from its current price and
   • have a consensus STRONG BUY rating.
   • In addition, CURLF has:
     • a 39% chance of Financial Distress within 2 years,
     • a NIL Short Interest,
     • a 38.9% Insider Ownership and
     • a Market Cap of $1.88B

In total, the sum total of the above 7 constituents in the munKNEE American Cannabis MSOs Index:

• had an average price change of +2.4% in April but are still -18.2% YTD. That compares with -12.4% in April and -27.5% YTD for the munKNEE Canadian Cannabis LPs Index and
• have an average 12-month price target representing a 222.8% increase from their average April 28th prices compared to the 5 constituents in the munKNEE Canadian Cannabis LPs Index which have a forward price target representing only a 92.0% increase.

If you are interested in buying a basket of American cannabis multi-sate operator stocks consider the AdvisorShares Pure U.S. Cannabis ETF (MSOS) that consists of the above 7 highlighted stocks plus an additional 41 smaller cap such stocks. It was -2.8% in April and is now -20.9% YTD, in comparison.

More By This Author:

Average Silver Forecast Of 26 Analysts: $31.82 By End Of 2023
A Conservative Way To Invest In Cannabis Stocks
Canadian Cannabis LPs Continue To Plummet In April